英文名 | Pseudouridine | ||
---|---|---|---|
CAS号 | 1445-07-4 | 分子量 | 244.20 |
产品编号 | NC00529 | MDL | MFCD00038458 |
外观与形状 | Off-white to white solid | 熔点 | |
纯度 | 97% | 沸点 | 598.4°C at 760 mmHg |
分子式 | C9H12N2O6 | 闪点 |
象形图 |
![]() |
||
警示语 | Warning | Class: | |
警告声明 | H302-H315-H319-H335 | UN#: | |
危险声明 | P261-P305+P351+P338 | Packing Group: |
KO-539 is a novel, once-daily, oral investigational drug candidate targeting the menin-KMT2A/MLL protein-protein interaction for treatment of genetically defined AML patients with high unmet need; In preclinical models, KO-539 inhibits the KMT2A/MLL protein complex and has downstream effects on HOXA9/MEIS1 expression. KO-539 has received Orphan Drug Designation from the U.S. Food and Drug Administration for the treatment of AML.
CAS No. | 2140-72-9 |
产品编号 | NC00723 |
纯度 | 97% |
CAS No. | 2140-76-3 |
产品编号 | NC00722 |
纯度 | 97% |
CAS No. | 2140-71-8 |
产品编号 | NC00720 |
纯度 | 97% |
CAS No. | 603130-12-7 |
产品编号 | NC00704 |
纯度 |
CAS No. | 1445-07-4 |
产品编号 | NC00529 |
纯度 | 97% |